期刊文献+

Gastric Adenocarcinoma at the Joliot Curie Institute in Dakar: Epidemiological, Diagnostic and Therapeutic Aspects about 54 Cases

Gastric Adenocarcinoma at the Joliot Curie Institute in Dakar: Epidemiological, Diagnostic and Therapeutic Aspects about 54 Cases
下载PDF
导出
摘要 <strong>Objectives:</strong><span><span><span style="font-family:;" "=""><span style="font-family:Verdana;"> To study the epidemiological, diagnostic, therapeutic </span><span style="font-family:Verdana;">and</span><span style="font-family:Verdana;"> prognostic aspects of gastric adenocarcinoma at the Joliot Curie Institute in Dakar. </span><b><span style="font-family:Verdana;">Materials and Methods: </span></b><span style="font-family:Verdana;">We conducted a retrospective study over </span><span style="font-family:Verdana;">a seven-year period</span><span style="font-family:Verdana;"> from January 2010 to December 2017 at the Joliot Curie Institute in Dakar. All cases of gastric adenocarcinoma proven by </span><span style="font-family:Verdana;">fibroscopy</span><span style="font-family:Verdana;"> followed by histology or proven on the histological analysis of a surgical specimen were taken into account. The parameters studied were age, risk factors, stages of the disease, treatment </span><span style="font-family:Verdana;">and</span><span style="font-family:Verdana;"> prognosis. </span><b><span style="font-family:Verdana;">Results:</span></b><span style="font-family:Verdana;"> There were 54 cases of gastric adenocarcinoma </span><span style="font-family:Verdana;">over a period of</span><span style="font-family:Verdana;"> 7 years. The average age was 54.74 years with extremes of 25 and 84 years. A male predominance was noted (35/54). The main risk factors found were alcohol (5/54), tobacco (13/54), </span><i><span style="font-family:Verdana;">Helicobacter </span><span style="font-family:Verdana;">pilori</span></i><span style="font-family:Verdana;"> (4/54), gastric ulcer (12/54). Epigastralgia was the most frequent clinical manifestation. </span><span style="font-family:Verdana;">FOGD</span><span style="font-family:Verdana;"> was carried out in 77.8% of patients. Histology was obtained before surgery in 40 patients (74.1% of cases) and </span><span style="font-family:Verdana;">on</span><span style="font-family:Verdana;"> the operating room in 14 patients (25.9%). Patients were classified as stage II in 2/54 cases, stage III in 5/54 cases </span><span style="font-family:Verdana;">and</span><span style="font-family:Verdana;"> stage IV in 47/54 cases. Gastro-entero-anastomosis was the main surgical procedure performed. External radiotherapy was performed in 1/54 patients. Chemotherapy was done in 52/54 patients, 96.3% of the cases. It was palliative in 66.7% of cases, neoadjuvant in 1.9% of cases, adjuvant in 24.1% of cases, perioperative in 3.7% of cases. Mortality was 79.6%. Patient survival times were relatively short: in less than 6 months 24/54 cases, 13/54 cases between 6</span></span></span></span><span><span><span style="font-family:;" "=""> </span></span></span><span style="font-family:Verdana;"><span style="font-family:Verdana;"><span style="font-family:Verdana;">-</span></span></span><span><span><span style="font-family:;" "=""> </span></span></span><span style="font-family:Verdana;"><span style="font-family:Verdana;"><span style="font-family:Verdana;">12 months, 5/54 cases between 13</span></span></span><span><span><span style="font-family:;" "=""> </span></span></span><span style="font-family:Verdana;"><span style="font-family:Verdana;"><span style="font-family:Verdana;">-</span></span></span><span><span><span style="font-family:;" "=""> </span></span></span><span><span><span style="font-family:;" "=""><span style="font-family:Verdana;">24 months </span><span style="font-family:Verdana;">and</span><span style="font-family:Verdana;"> 6/54 cases beyond 24 months. 6/54 patients were lost from view. </span><b><span style="font-family:Verdana;">Conclusion:</span></b><span style="font-family:Verdana;"> Gastric adenocarcinoma is diagnosed late</span></span></span></span><span style="font-family:Verdana;"><span style="font-family:Verdana;"><span style="font-family:Verdana;">ly</span></span></span><span style="font-family:Verdana;"><span style="font-family:Verdana;"><span style="font-family:Verdana;"> in our conditions. It is responsible for a high mortality rate. Palliative treatment is often the only option because of the delay in diagnosis.</span></span></span> <strong>Objectives:</strong><span><span><span style="font-family:;" "=""><span style="font-family:Verdana;"> To study the epidemiological, diagnostic, therapeutic </span><span style="font-family:Verdana;">and</span><span style="font-family:Verdana;"> prognostic aspects of gastric adenocarcinoma at the Joliot Curie Institute in Dakar. </span><b><span style="font-family:Verdana;">Materials and Methods: </span></b><span style="font-family:Verdana;">We conducted a retrospective study over </span><span style="font-family:Verdana;">a seven-year period</span><span style="font-family:Verdana;"> from January 2010 to December 2017 at the Joliot Curie Institute in Dakar. All cases of gastric adenocarcinoma proven by </span><span style="font-family:Verdana;">fibroscopy</span><span style="font-family:Verdana;"> followed by histology or proven on the histological analysis of a surgical specimen were taken into account. The parameters studied were age, risk factors, stages of the disease, treatment </span><span style="font-family:Verdana;">and</span><span style="font-family:Verdana;"> prognosis. </span><b><span style="font-family:Verdana;">Results:</span></b><span style="font-family:Verdana;"> There were 54 cases of gastric adenocarcinoma </span><span style="font-family:Verdana;">over a period of</span><span style="font-family:Verdana;"> 7 years. The average age was 54.74 years with extremes of 25 and 84 years. A male predominance was noted (35/54). The main risk factors found were alcohol (5/54), tobacco (13/54), </span><i><span style="font-family:Verdana;">Helicobacter </span><span style="font-family:Verdana;">pilori</span></i><span style="font-family:Verdana;"> (4/54), gastric ulcer (12/54). Epigastralgia was the most frequent clinical manifestation. </span><span style="font-family:Verdana;">FOGD</span><span style="font-family:Verdana;"> was carried out in 77.8% of patients. Histology was obtained before surgery in 40 patients (74.1% of cases) and </span><span style="font-family:Verdana;">on</span><span style="font-family:Verdana;"> the operating room in 14 patients (25.9%). Patients were classified as stage II in 2/54 cases, stage III in 5/54 cases </span><span style="font-family:Verdana;">and</span><span style="font-family:Verdana;"> stage IV in 47/54 cases. Gastro-entero-anastomosis was the main surgical procedure performed. External radiotherapy was performed in 1/54 patients. Chemotherapy was done in 52/54 patients, 96.3% of the cases. It was palliative in 66.7% of cases, neoadjuvant in 1.9% of cases, adjuvant in 24.1% of cases, perioperative in 3.7% of cases. Mortality was 79.6%. Patient survival times were relatively short: in less than 6 months 24/54 cases, 13/54 cases between 6</span></span></span></span><span><span><span style="font-family:;" "=""> </span></span></span><span style="font-family:Verdana;"><span style="font-family:Verdana;"><span style="font-family:Verdana;">-</span></span></span><span><span><span style="font-family:;" "=""> </span></span></span><span style="font-family:Verdana;"><span style="font-family:Verdana;"><span style="font-family:Verdana;">12 months, 5/54 cases between 13</span></span></span><span><span><span style="font-family:;" "=""> </span></span></span><span style="font-family:Verdana;"><span style="font-family:Verdana;"><span style="font-family:Verdana;">-</span></span></span><span><span><span style="font-family:;" "=""> </span></span></span><span><span><span style="font-family:;" "=""><span style="font-family:Verdana;">24 months </span><span style="font-family:Verdana;">and</span><span style="font-family:Verdana;"> 6/54 cases beyond 24 months. 6/54 patients were lost from view. </span><b><span style="font-family:Verdana;">Conclusion:</span></b><span style="font-family:Verdana;"> Gastric adenocarcinoma is diagnosed late</span></span></span></span><span style="font-family:Verdana;"><span style="font-family:Verdana;"><span style="font-family:Verdana;">ly</span></span></span><span style="font-family:Verdana;"><span style="font-family:Verdana;"><span style="font-family:Verdana;"> in our conditions. It is responsible for a high mortality rate. Palliative treatment is often the only option because of the delay in diagnosis.</span></span></span>
作者 Kanta Ka Doudou Diouf Sidy Ka El Hadj Amadou Sall Daniele Presti Mamadou Moustapha Dieng Papa Macoumba Gaye Ahmadou Dem Kanta Ka;Doudou Diouf;Sidy Ka;El Hadj Amadou Sall;Daniele Presti;Mamadou Moustapha Dieng;Papa Macoumba Gaye;Ahmadou Dem(Radiotherapy Department, CHNU Dalal Jamm, Guédiawaye, Senegal;Oncology Department, Institute Joliot Curie, Dakar, Senegal;Cheikh Anta Diop University of Dakar, Dakar, Senegal;Medical Oncology Service, ICS Maugeri IRCCS SpA, University of Pavia, Pavia, Italy)
出处 《Journal of Cancer Therapy》 2021年第3期136-145,共10页 癌症治疗(英文)
关键词 ADENOCARCINOMA Gastric Survival Adenocarcinoma Gastric Survival
  • 相关文献

参考文献1

二级参考文献1

共引文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部